| Period Ending | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 |
|---|
|
Total Revenue
|
110,061
|
167,252
|
353,890
|
153,028
| | Cost of Revenue | 75,033 | 107,046 | 201,562 | 87,030 | | |
Gross Profit
|
35,028
|
60,206
|
152,328
|
65,998
| |
|
Operating Expenses |
|
Research Development | 18,767 | 13,939 | 15,248 | 13,344 |
|
Selling General and Administrative | 8,608 | 19,115 | 18,404 | 18,090 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 2,538 | 2,547 | 2,546 | 2,822 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
5,115
|
24,605
|
116,130
|
31,742
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (404) | (479) | (35) | 2,260 |
|
Earnings Before Interest And Taxes | 4,711 | 24,126 | 116,095 | 34,002 |
|
Interest Expense | 1,620 | 979 | 799 | 6,827 |
|
Income Before Tax | 3,091 | 23,147 | 115,296 | 27,175 |
|
Income Tax Expense | 747 | 8,390 | 36,223 | 11,835 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,344 | 14,757 | 79,073 | 15,340 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
2,344
|
14,757
|
79,073
|
15,340
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,344
|
14,757
|
79,073
|
15,340
|
|
0.10(2.38%) 9:57AM EDT - Nasdaq Real Time Price